Byron Martina is a Virologist and CSO with a background in Immunology and Infectious diseases. Currently serving as the CSO at Protinhi Therapeutics since November 2021, Byron has a successful track record in various leadership roles within the bioservices and healthcare research industry. With a PhD in Virology from Erasmus University Rotterdam and an MSc in Immunology, Byron brings a wealth of knowledge and expertise to his current and previous positions at Artemis Bioservices, Artemis Bio-Support, Artemis One Health Research Foundation, and Erasmus MC.
Artemis Bioservices (formerly known as Artemis Bio-Support)
Artemis Bioservices is a private, non-profit CRO specialized in vaccine and antiviral evaluation. Vision of Artemis Bioservices: The vision of Artemis Bioservices is to become a strategic partner in the process of antiviral, antibody and vaccine development against emerging viral diseases. Mission of Artemis Bioservices: To assist biotech and biopharmaceutical companies to accelerate the development and licensing of safe and effective antiviral intervention strategies, in particular against emerging, zoonotic and arboviral diseases, by offering customized in-vitro testing and in-vivo immunogenicity and efficacy testing capabilities Artemis Bioservices provides high quality preclinical and clinical services to developers of antiviral intervention strategies who want to evaluate the immunogenicity and efficacy of candidate products, especially against emerging, vector-borne and zoonotic viruses. Artemis Bioservices has recently been certified GLP compliant. Artemis Bioservices is located in the Yes!Delft Labs building, at Molengraaffsingel 10, 2629 JD, Delft, The Netherlands.